- Home
- XERS vs MOV Comparison
XERS vs MOV Comparison
Compare XERS & MOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- MOV
- Stock Information
- Founded
- XERS 2005
- MOV 1961
- Country
- XERS United States
- MOV United States
- Employees
- XERS N/A
- MOV N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- MOV Consumer Specialties
- Sector
- XERS Health Care
- MOV Consumer Discretionary
- Exchange
- XERS Nasdaq
- MOV Nasdaq
- Market Cap
- XERS 444.0M
- MOV 421.3M
- IPO Year
- XERS 2018
- MOV 1993
- Fundamental
- Price
- XERS $3.09
- MOV $19.63
- Analyst Decision
- XERS Buy
- MOV Strong Buy
- Analyst Count
- XERS 3
- MOV 1
- Target Price
- XERS $4.87
- MOV $41.00
- AVG Volume (30 Days)
- XERS 1.9M
- MOV 164.0K
- Earning Date
- XERS 11-08-2024
- MOV 12-03-2024
- Dividend Yield
- XERS N/A
- MOV 7.14%
- EPS Growth
- XERS N/A
- MOV N/A
- EPS
- XERS N/A
- MOV 1.59
- Revenue
- XERS $187,361,000.00
- MOV $663,288,000.00
- Revenue This Year
- XERS $20.35
- MOV N/A
- Revenue Next Year
- XERS $16.14
- MOV $5.01
- P/E Ratio
- XERS N/A
- MOV $12.33
- Revenue Growth
- XERS 22.72
- MOV N/A
- 52 Week Low
- XERS $1.69
- MOV $17.86
- 52 Week High
- XERS $3.64
- MOV $31.44
- Technical
- Relative Strength Index (RSI)
- XERS 49.74
- MOV 54.36
- Support Level
- XERS $2.82
- MOV $18.34
- Resistance Level
- XERS $3.12
- MOV $19.81
- Average True Range (ATR)
- XERS 0.18
- MOV 0.52
- MACD
- XERS -0.03
- MOV 0.01
- Stochastic Oscillator
- XERS 32.93
- MOV 59.72
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology. The company has three commercially available products, Gvoke, ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis, the first FDA-approved therapy for primary periodic paralysis, and Recorlev, approved by the FDA for the treatment of endogenous hypercortisolemia in adult patients with Cushing's Syndrome. The Company also has a pipeline of development programs to bring new products forward using its proprietary formulation science, XeriSol and XeriJect.
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.